Somaxon Pharmaceuticals, Inc.(SOMX)- NASDAQ
SOMX is defunct.
  • Feb. 5, 2013, 7:11 PM

    Somaxon Pharmaceuticals (SOMX) says it's entered into a settlement agreement with Actavis Elizabeth LLC and Actavis to resolve four patent litigation suits involving its Silenor 3 mg and 6 mg tablets. The settlement grants Somaxon an additional seven years protection on its patent, allowing Actavis the right to begin selling a generic version of Silenor on January 1, 2020, or earlier under certain circumstances. Shares +12% AH.

    | Feb. 5, 2013, 7:11 PM
  • Dec. 17, 2012, 4:51 PM

    Somaxon Pharmaceuticals (SOMX) says that its licensee Paladin Labs has received approval from Health Canada for its New Drug Submission for its insomnia treatment Silenor. The drug's launch is expected to around mid-2013. Shares +1% AH.

    | Dec. 17, 2012, 4:51 PM
  • Dec. 11, 2012, 12:45 PM
    Midday top 10 gainers: BGMD +146%. SOMX +75%. ACUR +56%. TNS +43%. ULBI +18%. MEAD +16%. ESYS +15%. SZYM +14%. GTXI +13%. CLWR +12%.
    Midday top 10 Losers: CBMX -11%. ESIO -11%. AMCN -9%. SEV -9%. GGAL -8%. SPW -8%. TELK -7%. [[JW-A]] -7%. MGLN -7%. SXC -7%.
    | Dec. 11, 2012, 12:45 PM | 2 Comments
  • Dec. 11, 2012, 9:10 AM

    Somaxon Pharmaceuticals (SOMX) +103.4% premarket after agreeing to be acquired by Pernix Therapeutics (PTX) in a stock-for-stock transaction valued at $25M.

    | Dec. 11, 2012, 9:10 AM
  • Dec. 11, 2012, 9:10 AM
    Premarket gainers: SOMX +101%. TNS +45%. VE +6%. CLDX +5%. URBN +5%.
    Losers: ESIO -19%.
    | Dec. 11, 2012, 9:10 AM
  • Nov. 26, 2012, 12:45 PM
    Midday top 10 gainers: CBAK +80%. ENMD +23%. ANAD +19%. SSE +17%. HOGS +16%. SBLK +15%. CLSN +14%. SOMX +15%. GALT +14%. ACRX +12%. Midday top 10 Losers: SAB -14%. MMR -13%. CNIT -12%. CCCL -14%. BZ -9%. ZLC -9%. OXF -8%. MEIP -8%. PSTR -8%. AXX -7%.
    | Nov. 26, 2012, 12:45 PM
  • Jul. 20, 2012, 10:38 AM

    Somaxon Pharmaceuticals (SOMX -19%) gets smacked after saying its selling approximately 9.4M shares of its common stock and warrants in a registered direct offering to purchase up to approximately 4.7M shares of its common stock to institutional investors at $0.32 per share and per warrant. Aggregate proceeds from the transaction will total approximately $3.0M.

    | Jul. 20, 2012, 10:38 AM
  • Jul. 18, 2012, 11:43 AM

    Somaxon (SOMX +83%) soars this morning - after initially surging over 150% in pre-open trading - on the back of yesterday's announcement of its litigation settlement over Silenor with Mylan (MYL +0.8%) and Par Pharmaceuticals. The company added that it sees higher Q2 net sales for Silenor, now seeing revenue of approximately $2.8M to $2.9M, up from reported sales of $2.7M in Q1.

    | Jul. 18, 2012, 11:43 AM
  • Jul. 17, 2012, 4:30 PM

    Somaxon Pharmaceuticals (SOMX) settles its patent litigation suit with Mylan (MYL) and Par Pharmaceutical (PRX) involving Silenor 3 mg and 6 mg tablets. The settlement grants MYL the exclusive right to begin selling a generic version of Silenor on January 1, 2020, and PRX the right to begin selling a generic version 180 days after a third party generic version is first sold in the U.S. under a license from Somaxon.

    | Jul. 17, 2012, 4:30 PM
  • Oct. 3, 2011, 4:50 PM

    Somaxon Pharmaceuticals (SOMX) jumps in post-trade after saying it had a productive meeting with the FDA relating to the over-the-counter development program for its insomnia drug Silenor, developed jointly with Procter & Gamble (PG). SOMX +22.5% AH.

    | Oct. 3, 2011, 4:50 PM
  • Feb. 23, 2011, 9:00 AM

    Premarket gainers: VRTX +17%. OCLR +10%. CHS +5%. DTV +6%. CTIC +5%. SNV +4%. SOMX +4%.
    Losers: SATC -14%. HPQ -9%. CNXT -6%. GRMN -6%.

    | Feb. 23, 2011, 9:00 AM
  • Feb. 8, 2011, 9:00 AM

    Premarket gainers: RHB +46%. KND +26%. CNXT +17%. XIDE +15%. SOMX +6%. CXZ +5%. CPST +5%. MT +5%. BYD +4%. MGM +4%. NTWK +4%. MOTR +4%. CCME +4%.
    Losers: BR -12%. GLUU -7%. OLP -6%. TEVA -5%. RNN -5%. BBEP -5%. PPNT -5%. AVP -4%. KTOS -4%.

    | Feb. 8, 2011, 9:00 AM
  • Nov. 30, 2010, 9:00 AM

    Premarket gainers: BEZ +40%. KERX +9%. SOMX +6%. AEZS +4%.
    Losers: CTIC -9%. ING -7%. IRE -7%. BBVA -5%. SDRL -5%. AIB -4%. STX -4%. DB -4%. BCS -4%.

    | Nov. 30, 2010, 9:00 AM
  • Sep. 7, 2010, 9:00 AM

    Premarket gainers: ORCL +8%. CASY +7%. RSCR +7%. ARNA +5%. SOMX +5%.
    Losers: IDIX -51%. CSKI -26%. BCS -5%. IRE -5%. RTP -4%. ASML -4%.

    | Sep. 7, 2010, 9:00 AM
  • Aug. 25, 2010, 9:20 AM

    Premarket gainers: SOMX +28%. ACTG +7%.
    Losers: AIB -7%. IRE -6%.

    | Aug. 25, 2010, 9:20 AM
  • Aug. 25, 2010, 8:03 AM

    Shares of Somaxon Pharmaceuticals (SOMX) are +31.2% premarket after the company announced a co-promotion pact with Procter & Gamble (PG) to market its insomnia drug, Silenor. PG -0.3%. (PR)

    | Aug. 25, 2010, 8:03 AM